EdgeMarketInstruments › NCNA

NCNA — NuCana plc

US Healthcare Pharma & biotech equity
1.52 -1.94% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 1.21 · high 7.02

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-09-28.

Performance

1 day-1.94%
1 week-4.40%
1 month+14.29%
3 months-25.12%
6 months-27.62%
Year to date-58.24%
1 year-51.13%
3 years-99.96%
5 years-99.99%

Technicals

RSI 1465.5
vs 50-day avg+2.93%
vs 200-day avg-35.35%
Volatility 1y91.6%
Max drawdown 1y-82.76%
Avg volume 30d36.6K
Daily bars held2,236
History from2017-09-28

Largest institutional holders

managervalueshares
Glass Jacobson Investment Advisors llc21.0K15.0K
CITADEL ADVISORS LLC19.5K13.9K
JANE STREET GROUP, LLC14.7K10.5K
RHUMBLINE ADVISERS5.2K3.7K
Virtu Financial LLC1913.4K
MORGAN STANLEY32
Caitong International Asset Management Co., Ltd32
ACADIAN ASSET MANAGEMENT LLC02

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d37.8% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about NCNA

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open NCNA in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →